曾育 谭晏林 何易
【摘 要】目的:研究分析化疗联合深部热疗治疗肺癌恶性胸腔积液的临床作用。方法:选取我院2016年4月至2017年7月间接受治疗的肺癌恶性胸腔积液患者80例,将其平均分为研究组和对照组各50例,对照组患者采用常规治疗方式,研究组则在常规基础上进行化疗联合深部热疗治疗方式,观察对比两组患者临床效果及生活质量量表评分。结果:观察组患者总有效率(95.00%)明显高于对照组(75.00%),两组患者对比差异具有统计学意义(P<0.05);两组患者治疗前生活质量评分对比差异不明显,无统计学意义(P>0.05),治疗后,评分均上升,且组间比较观察组明显优于对照组,具有统计学意义(P<0.01)。结论:化疗联合深部热疗治疗肺癌恶性胸腔积液具有较高的临床价值,有效缓解患者病情,提高生活质量,且安全性高,值得推广。
【关键词】化疗联合深部热疗;肺癌恶性胸腔积液;临床研究
Abstract Objective: To study the clinical effect of chemotherapy combined with deep hyperthermia in the treatment of malignant pleural effusion of lung cancer. Methods : 80 patients with malignant pleural effusion from lung cancer in our hospital from April 2016 to July 2017 were selected. The average was divided into 50 cases in the study group and the control group. The patients in the control group were treated with routine treatment, and the study group was treated with chemotherapy combined with deep hyperthermia on the basis of routine nursing.The clinical effects and quality of life scale (QOL) score were compared between the two groups. Results: the total effective rate of the patients in the observation group (95%) was significantly higher than that of the control group (75%).The difference between the two groups was statistically significant (P<0.05).The difference of quality of life scores between the two groups was not significant before treatment, and there was no statistical significance (P > 0.05). After treatment, the scores were all increased, and the comparison group between the groups was significantly better than the control group, with statistical significance (P<0.01). Conclusion: chemotherapy combined with deep hyperthermia is of high clinical value in the treatment of malignant pleural effusion of lung cancer.It can effectively relieve the patient's condition, improve the quality of life, and have high safety. It is worth popularizing.
Key words: chemotherapy combined with deep hyperthermia;Malignant pleural effusion of lung cancer;clinical research
【中圖分类号】 R715【文献标识码】 B 【文章编号】 1672-3783(2018)04-03-086-01
恶性胸腔积液临床中大多由肺癌、淋巴癌、乳腺癌等恶性肿瘤疾病引发,肺癌恶性胸腔积液临床表现为贫血、乏力、呼吸困难、胸闷气短等肺功能衰弱现象,另外,患者若出现腹腔积液会伴随腹痛、腹胀等症状,严重影响患者身体健康,增加患者及其家属心理负担,降低患者生活质量[1]。笔者为研究化疗联合深部热疗治疗肺癌恶性胸腔积液的临床价值,特选取我院80例肺癌恶性胸腔积液患者进行临床试验对照,作出如下总结。
1 资料与方法
1.1 一般资料 从我院2016年4月至2017年7月间接受治疗的肺癌恶性胸腔积液患者中随机抽选80例,将其平均分为研究组(n=40)和对照组(n=40),对照组患者采用常规治疗方式,研究组则在常规基础上进行化疗联合深部热疗治疗方式。对照组中,男30例,女10例,年龄为29~65岁,平均年龄为(36.72±7.36)岁,其中腺癌10例,小细胞肺癌23例,鳞癌7例;……